Eversept Partners, LP Insulet Corp Transaction History

Eversept Partners, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$154.67 - $290.89 $3.29 Million - $6.2 Million	21,299 New	21,299 $3.4 Million
Q1 2022 May 16, 2022	SELL	$194.8 - $275.7 $5.88 Million - $8.32 Million	-30,172 Closed	0 $0
Q4 2021 Nov 08, 2023	BUY	$255.32 - $318.29 $7.7 Million - $9.6 Million	30,172 New	30,172 $8.03 Million
Q4 2021 Feb 14, 2022	BUY	$255.32 - $318.29 $7.7 Million - $9.6 Million	30,172 New	30,172 $8.03 Million
Q4 2018 Feb 13, 2019	SELL	$73.27 - $105.19 $642,211 - $921,990	-8,765 Closed	0 $0
Q3 2018 Nov 08, 2023	BUY	$81.43 - $108.13 $713,733 - $947,759	8,765 New	8,765 $928,000
Q3 2018 Nov 14, 2018	BUY	$81.43 - $108.13 $713,733 - $947,759	8,765 New	8,765 $929,000

685

62.7M

640K

881K

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $18.1B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

Stay updated on Eversept Partners, LP with notifications on news.